Clioquinol inhibits angiogenesis by promoting VEGFR2 degradation and synergizes with AKT inhibition to suppress triple-negative breast cancer vascularization.

Saved in:
Bibliographic Details
Title: Clioquinol inhibits angiogenesis by promoting VEGFR2 degradation and synergizes with AKT inhibition to suppress triple-negative breast cancer vascularization.
Authors: Gu Y; Institute for Clinical and Experimental Surgery, Saarland University, 66421, Homburg, Saarland, Germany. yuan.gu@uks.eu., Tang T; Institute for Clinical and Experimental Surgery, Saarland University, 66421, Homburg, Saarland, Germany., Qiu M; Institute for Clinical and Experimental Surgery, Saarland University, 66421, Homburg, Saarland, Germany.; Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, China., Wang H; Shaanxi University of Chinese Medicine, Shaanxi, 712046, China., Ampofo E; Institute for Clinical and Experimental Surgery, Saarland University, 66421, Homburg, Saarland, Germany., Menger MD; Institute for Clinical and Experimental Surgery, Saarland University, 66421, Homburg, Saarland, Germany., Laschke MW; Institute for Clinical and Experimental Surgery, Saarland University, 66421, Homburg, Saarland, Germany.
Source: Angiogenesis [Angiogenesis] 2025 Feb 03; Vol. 28 (2), pp. 13. Date of Electronic Publication: 2025 Feb 03.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Country of Publication: Germany NLM ID: 9814575 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7209 (Electronic) Linking ISSN: 09696970 NLM ISO Abbreviation: Angiogenesis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39899169
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Clioquinol inhibits angiogenesis by promoting VEGFR2 degradation and synergizes with AKT inhibition to suppress triple-negative breast cancer vascularization.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gu+Y%22">Gu Y</searchLink>; Institute for Clinical and Experimental Surgery, Saarland University, 66421, Homburg, Saarland, Germany. yuan.gu@uks.eu.<br /><searchLink fieldCode="AU" term="%22Tang+T%22">Tang T</searchLink>; Institute for Clinical and Experimental Surgery, Saarland University, 66421, Homburg, Saarland, Germany.<br /><searchLink fieldCode="AU" term="%22Qiu+M%22">Qiu M</searchLink>; Institute for Clinical and Experimental Surgery, Saarland University, 66421, Homburg, Saarland, Germany.; Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530021, China.<br /><searchLink fieldCode="AU" term="%22Wang+H%22">Wang H</searchLink>; Shaanxi University of Chinese Medicine, Shaanxi, 712046, China.<br /><searchLink fieldCode="AU" term="%22Ampofo+E%22">Ampofo E</searchLink>; Institute for Clinical and Experimental Surgery, Saarland University, 66421, Homburg, Saarland, Germany.<br /><searchLink fieldCode="AU" term="%22Menger+MD%22">Menger MD</searchLink>; Institute for Clinical and Experimental Surgery, Saarland University, 66421, Homburg, Saarland, Germany.<br /><searchLink fieldCode="AU" term="%22Laschke+MW%22">Laschke MW</searchLink>; Institute for Clinical and Experimental Surgery, Saarland University, 66421, Homburg, Saarland, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229814575%22">Angiogenesis</searchLink> [Angiogenesis] 2025 Feb 03; Vol. 28 (2), pp. 13. <i>Date of Electronic Publication: </i>2025 Feb 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9814575 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7209 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209696970%22">09696970 </searchLink><i>NLM ISO Abbreviation: </i>Angiogenesis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39899169
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10456-024-09965-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 13
    Titles:
      – TitleFull: Clioquinol inhibits angiogenesis by promoting VEGFR2 degradation and synergizes with AKT inhibition to suppress triple-negative breast cancer vascularization.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gu Y
      – PersonEntity:
          Name:
            NameFull: Tang T
      – PersonEntity:
          Name:
            NameFull: Qiu M
      – PersonEntity:
          Name:
            NameFull: Wang H
      – PersonEntity:
          Name:
            NameFull: Ampofo E
      – PersonEntity:
          Name:
            NameFull: Menger MD
      – PersonEntity:
          Name:
            NameFull: Laschke MW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 02
              Text: 2025 Feb 03
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7209
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Angiogenesis
              Type: main
ResultId 1